Pressure-derived indices of left ventricular isovolumic relaxation in patients with hypertrophic cardiomyopathy. 1983

D S Thompson, and P Wilmshurst, and S M Juul, and C B Waldron, and B S Jenkins, and D J Coltart, and M M Webb-Peploe

High fidelity measurements of left ventricular pressure were made at increasing pacing rates in 21 patients with hypertrophic cardiomyopathy and a control group of 11 patients investigated for chest pain who proved to have normal hearts. In both groups the fall in pressure during isovolumic relaxation from the point of min dp/dt approximated closely to a monoexponential, and could be described by a time constant and asymptote. The time constant shortened and the asymptote increased as heart rate rose in both groups. The time constant was longer and min dp/dt less in the cardiomyopathy group than controls at all heart rates. In the cardiomyopathy patients min dp/dt, but not the time constant, was related to systolic pressure. During pacing, eight cardiomyopathy patients developed metabolic evidence of myocardial ischaemia, but indices of relaxation did not differ between these eight and the other 13 either at basal heart rate or the highest pacing rate. In 10 cardiomyopathy patients measurements were repeated at comparable pacing rates after propranolol (0.2 mg/kg). Left ventricular end-diastolic pressure and indices of contractility decreased after the drug, but the time constant did not change. Eight patients received verapamil (20 mg) after which there were substantial reductions in systolic pressure and contractility. Min dp/dt decreased in proportion to systolic pressure, but the time constant was unchanged. At the highest pacing rate before drug administration three patients had abnormal lactate extraction which was corrected by either propranolol (one patient) or verapamil (two patients). Despite abolition of metabolic evidence of ischaemia, relaxation did not improve. It is concluded that abnormal isovolumic relaxation is common in patients with hypertrophic cardiomyopathy, but its severity correlates poorly with other features of the disease. Abnormal relaxation is not the result of ischaemia, and pressure derived indices of relaxation do not improve after the administration of propranolol or verapamil.

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008955 Models, Cardiovascular Theoretical representations that simulate the behavior or activity of the cardiovascular system, processes, or phenomena; includes the use of mathematical equations, computers and other electronic equipment. Cardiovascular Model,Cardiovascular Models,Model, Cardiovascular
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002304 Cardiac Pacing, Artificial Regulation of the rate of contraction of the heart muscles by an artificial pacemaker. Pacing, Cardiac, Artificial,Artificial Cardiac Pacing,Artificial Cardiac Pacings,Cardiac Pacings, Artificial,Pacing, Artificial Cardiac,Pacings, Artificial Cardiac
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic

Related Publications

D S Thompson, and P Wilmshurst, and S M Juul, and C B Waldron, and B S Jenkins, and D J Coltart, and M M Webb-Peploe
January 1983, Japanese circulation journal,
D S Thompson, and P Wilmshurst, and S M Juul, and C B Waldron, and B S Jenkins, and D J Coltart, and M M Webb-Peploe
June 1980, The American journal of cardiology,
D S Thompson, and P Wilmshurst, and S M Juul, and C B Waldron, and B S Jenkins, and D J Coltart, and M M Webb-Peploe
January 1984, Journal of the American College of Cardiology,
D S Thompson, and P Wilmshurst, and S M Juul, and C B Waldron, and B S Jenkins, and D J Coltart, and M M Webb-Peploe
March 2003, The Canadian journal of cardiology,
D S Thompson, and P Wilmshurst, and S M Juul, and C B Waldron, and B S Jenkins, and D J Coltart, and M M Webb-Peploe
January 1990, Progress in cardiovascular diseases,
D S Thompson, and P Wilmshurst, and S M Juul, and C B Waldron, and B S Jenkins, and D J Coltart, and M M Webb-Peploe
February 1997, Circulation,
D S Thompson, and P Wilmshurst, and S M Juul, and C B Waldron, and B S Jenkins, and D J Coltart, and M M Webb-Peploe
April 1982, Circulation,
D S Thompson, and P Wilmshurst, and S M Juul, and C B Waldron, and B S Jenkins, and D J Coltart, and M M Webb-Peploe
October 1991, European heart journal,
D S Thompson, and P Wilmshurst, and S M Juul, and C B Waldron, and B S Jenkins, and D J Coltart, and M M Webb-Peploe
January 1986, Journal of the American College of Cardiology,
D S Thompson, and P Wilmshurst, and S M Juul, and C B Waldron, and B S Jenkins, and D J Coltart, and M M Webb-Peploe
January 1995, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography,
Copied contents to your clipboard!